« Committe Votes to Approve Tetrabenazine for Chorea | Main | Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation »

Dec 7
Bed-Wetting Drug Gets FDA Warning

Desmopressin, a drug that limits the amount of water that is eliminated in the urine and also is used to prevent and control excessive thirst, urination and dehydration due to injury, surgery and certain medical conditions has received a U.S. Food and Drug warning update request.

ddavpThe FDA has requested that the manufactures of desmopressin update the prescribing information to include new information about severe hyponatremia, dangerously low levels of sodium in the body, and seizures. Children treated with desmopressin nasal spray for primary nocturnal enuresis (PNE/ bed wetting) are particularly susceptible and the drug is no longer indicated for the treatment of PNE.

According to the FDA 61 reports of seizures, 36 associated with the nasal spray form of the drug were reported. There were also reports of two deaths though the FDA said it was not clear whether the drug caused the reported deaths.

[Source: FDA]

 


1 Comments/Trackbacks




We came across your blog posting, and would like to advise that drugs do not address the root cause of bedwetting: A deep sleep disorder. If pills and nasal sprays are being used and show some effectiveness, once the drugs are discontinued, the bedwetting will resume. They are merely a temporary fix, and have many side effects. For 32 years, the Enuresis Treatment Center has successfully treated thousands of people from around the world by establishing a new and healthy pattern of sleep. The Enuresis Treatment Center cures bedwetting without the use of drugs. Physicians bring their own children for treatment instead of subjecting them to drugs. The Enuresis Treatment Center has put together an informative guide to understanding and treating bedwetting. This free bedwetting guide is available to download at www.freebedwettingguide.com.

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Committe Votes to Approve Tetrabenazine for Chorea | Main | Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation »

Advertise

Watch the Digital Health Revolution


Related Resources

recent comments

    sponsored ads



    subscribe


    Prefer Email?
    Subscribe below-

    Enter your Email:


    Powered by FeedBlitz What's this?

    Current News

    Support This Blog

    blogroll


    top blogs

    business social media

    Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

    BIZZlogos - Add your logo - free link to your site
    BIZZphotos - Add photos of your products and people
    BIZZprofiles - Submit your profile and build your online visibility
    BIZZspotlight - Spotlight your business with free links
    BIZZvideos - Videos about businesses, products and business people.
    BIZZbites - "Digg" for Business - Submit your articles and posts

    Know More Media - Health Care / Pharmaceutical / Fitness

    know more media network

    View Network Map

    Network Feed List (OPML)

    Know More Media Network
    Feed


    we support unitus

    PRWeb

    Influencer



    PharmaGazette is a member of the Know More Media network of business related blogs.

    Here are some current headlines from some of our business publications:

    ProductivityGoal

    CallCenterScript

    AdHurl

    TheBizofKnowledge

    LandingTheDeal

    CustomersAreAlways

    HealthCareVox

    BrainBasedBusiness

    TheInsurancePolicy

    MarketingBlurb